Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C11H14FNO3 |
| Molecular Weight | 226.2347 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
N[C@@H](CC1=CC=C(OCC[18F])C=C1)C(O)=O
InChI
InChIKey=QZZYPHBVOQMBAT-LRAGLOQXSA-N
InChI=1S/C11H14FNO3/c12-5-6-16-9-3-1-8(2-4-9)7-10(13)11(14)15/h1-4,10H,5-7,13H2,(H,14,15)/t10-/m0/s1/i12-1
| Molecular Formula | C11H14FNO3 |
| Molecular Weight | 226.2347 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
18F-FET (18F-Fluoroethyl-L-tyrosine) is a radiolabelled amino acid. It penetrates the blood-brain barrier by a specific amino acid transport system. In the brain, it is taken up into upregulated tumoral cells but not incorporated into proteins. It is used as a biomarker for positron emission tomography for imaging brain tumors, where it has higher specificity than 18F-FDG.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:01:17 GMT 2025
by
admin
on
Mon Mar 31 21:01:17 GMT 2025
|
| Record UNII |
1326R5J1IA
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
V09IX10
Created by
admin on Mon Mar 31 21:01:17 GMT 2025 , Edited by admin on Mon Mar 31 21:01:17 GMT 2025
|
||
|
FDA ORPHAN DRUG |
683619
Created by
admin on Mon Mar 31 21:01:17 GMT 2025 , Edited by admin on Mon Mar 31 21:01:17 GMT 2025
|
||
|
FDA ORPHAN DRUG |
934623
Created by
admin on Mon Mar 31 21:01:17 GMT 2025 , Edited by admin on Mon Mar 31 21:01:17 GMT 2025
|
||
|
FDA ORPHAN DRUG |
767920
Created by
admin on Mon Mar 31 21:01:17 GMT 2025 , Edited by admin on Mon Mar 31 21:01:17 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C60818
Created by
admin on Mon Mar 31 21:01:17 GMT 2025 , Edited by admin on Mon Mar 31 21:01:17 GMT 2025
|
PRIMARY | |||
|
LM-155
Created by
admin on Mon Mar 31 21:01:17 GMT 2025 , Edited by admin on Mon Mar 31 21:01:17 GMT 2025
|
PRIMARY | |||
|
DB15405
Created by
admin on Mon Mar 31 21:01:17 GMT 2025 , Edited by admin on Mon Mar 31 21:01:17 GMT 2025
|
PRIMARY | |||
|
178433-03-9
Created by
admin on Mon Mar 31 21:01:17 GMT 2025 , Edited by admin on Mon Mar 31 21:01:17 GMT 2025
|
PRIMARY | |||
|
DTXSID601045942
Created by
admin on Mon Mar 31 21:01:17 GMT 2025 , Edited by admin on Mon Mar 31 21:01:17 GMT 2025
|
PRIMARY | |||
|
100000169818
Created by
admin on Mon Mar 31 21:01:17 GMT 2025 , Edited by admin on Mon Mar 31 21:01:17 GMT 2025
|
PRIMARY | |||
|
1325243-02-4
Created by
admin on Mon Mar 31 21:01:17 GMT 2025 , Edited by admin on Mon Mar 31 21:01:17 GMT 2025
|
SUPERSEDED | |||
|
SUB183603
Created by
admin on Mon Mar 31 21:01:17 GMT 2025 , Edited by admin on Mon Mar 31 21:01:17 GMT 2025
|
PRIMARY | |||
|
1326R5J1IA
Created by
admin on Mon Mar 31 21:01:17 GMT 2025 , Edited by admin on Mon Mar 31 21:01:17 GMT 2025
|
PRIMARY | |||
|
9834479
Created by
admin on Mon Mar 31 21:01:17 GMT 2025 , Edited by admin on Mon Mar 31 21:01:17 GMT 2025
|
PRIMARY | |||
|
Fluoroethyl-L-tyrosine (18F)
Created by
admin on Mon Mar 31 21:01:17 GMT 2025 , Edited by admin on Mon Mar 31 21:01:17 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TRANSPORTER -> SUBSTRATE |
|
||
|
TARGET -> SUBSTRATE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|
